571 related articles for article (PubMed ID: 11158032)
21. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
[TBL] [Abstract][Full Text] [Related]
22. Iodine-131 MIBG imaging in multiple endocrine neoplasia type 2B.
Yamamoto Y; Isobe Y; Nishiyama Y; Takashima H; Ohkawa M; Kihara M; Matsusaka K; Miyauchi A; Kobayashi S; Tanabe M
Clin Nucl Med; 1998 Jan; 23(1):13-5. PubMed ID: 9442958
[TBL] [Abstract][Full Text] [Related]
23. Intraoperative localization of malignant pheochromocytoma by 123-I-metaiodobenzylguanidine single probe measurement.
Lehnert H; Weber P; Nägele-Wöhrle B; von Bülow M; Eissner D; Schweden F; Junginger T; Schrezenmeir J; Krause U; Beyer J
Klin Wochenschr; 1988 Jan; 66(2):61-4. PubMed ID: 3347006
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours.
Maurea S; Klain M; Caraco C; Ziviello M; Salvatore M
Nucl Med Commun; 2002 Oct; 23(10):951-60. PubMed ID: 12352593
[TBL] [Abstract][Full Text] [Related]
25. The utility of metaiodobenzylguanidine (MIBG) scintigraphy in patients with pheochromocytoma.
Greenblatt DY; Shenker Y; Chen H
Ann Surg Oncol; 2008 Mar; 15(3):900-5. PubMed ID: 18193324
[TBL] [Abstract][Full Text] [Related]
26. Current concepts on the diagnostic use of MIBG in children.
Shulkin BL; Shapiro B
J Nucl Med; 1998 Apr; 39(4):679-88. PubMed ID: 9544682
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging.
Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K
Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024
[TBL] [Abstract][Full Text] [Related]
28. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
Ruike Y; Suzuki S; Yokote K
Clin Nucl Med; 2024 May; 49(5):419-426. PubMed ID: 38546331
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of clinical utility of 123I-MIBG scintigraphy in localization of tumors of sympathetic and adrenomedullary origin--a report of multicenter phase III clinical trials].
Ishii K; Kubo A; Kusakabe K; Murata H; Masaki H; Horiike S; Hayashi A; Hara Y
Kaku Igaku; 2000 Jan; 37(1):43-59. PubMed ID: 10714067
[TBL] [Abstract][Full Text] [Related]
30. Tumour size: the only predictive factor for 131I MIBG uptake in phaeochromocytoma and paraganglioma.
Nguyen HH; Proye CA; Carnaille B; Combemale F; Pattou FN; Huglo D
Aust N Z J Surg; 1999 May; 69(5):350-3. PubMed ID: 10353549
[TBL] [Abstract][Full Text] [Related]
31. [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].
Padberg BC; Rordorf T; Suter SL; Pfeiffer D; Wild D; Schröder S
Pathologe; 2007 Jul; 28(4):281-4. PubMed ID: 16673076
[TBL] [Abstract][Full Text] [Related]
32. Phaeochromocytomas and paragangliomas: A difference in disease behaviour and clinical outcomes.
Ezzat Abdel-Aziz T; Prete F; Conway G; Gaze M; Bomanji J; Bouloux P; Khoo B; Caplin M; Mushtaq I; Smart J; Kurzawinski TR
J Surg Oncol; 2015 Oct; 112(5):486-91. PubMed ID: 26337393
[TBL] [Abstract][Full Text] [Related]
33. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
[TBL] [Abstract][Full Text] [Related]
34. Imaging of neuroendocrine tumors.
Rufini V; Calcagni ML; Baum RP
Semin Nucl Med; 2006 Jul; 36(3):228-47. PubMed ID: 16762613
[TBL] [Abstract][Full Text] [Related]
35. The utility of metaiodobenzylguanidine single photon emission computed tomography/computed tomography (MIBG SPECT/CT) for the diagnosis of pheochromocytoma.
Meyer-Rochow GY; Schembri GP; Benn DE; Sywak MS; Delbridge LW; Robinson BG; Roach PJ; Sidhu SB
Ann Surg Oncol; 2010 Feb; 17(2):392-400. PubMed ID: 19949879
[TBL] [Abstract][Full Text] [Related]
36. 111In-octreotide is superior to 123I-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas.
Koopmans KP; Jager PL; Kema IP; Kerstens MN; Albers F; Dullaart RP
J Nucl Med; 2008 Aug; 49(8):1232-7. PubMed ID: 18632829
[TBL] [Abstract][Full Text] [Related]
37. Alteration of myocardial metaiodobenzylguanidine uptake after treatment of phaeochromocytoma and neuroblastoma.
Suga K; Ogasawara N; Ariga M; Motoyama K; Hara A; Kume N; Matsunaga N
Eur J Nucl Med; 2000 May; 27(5):574-82. PubMed ID: 10853814
[TBL] [Abstract][Full Text] [Related]
38. Meta-[131I]iodobenzylguanidine in the scintigraphic evaluation of neural crest tumors.
Zagar I; Han R; Mitrovic S
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):13-6. PubMed ID: 9002742
[TBL] [Abstract][Full Text] [Related]
39. Superiority of 6-[18F]-fluorodopamine positron emission tomography versus [131I]-metaiodobenzylguanidine scintigraphy in the localization of metastatic pheochromocytoma.
Ilias I; Yu J; Carrasquillo JA; Chen CC; Eisenhofer G; Whatley M; McElroy B; Pacak K
J Clin Endocrinol Metab; 2003 Sep; 88(9):4083-7. PubMed ID: 12970267
[TBL] [Abstract][Full Text] [Related]
40. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
Ezziddin S; Logvinski T; Yong-Hing C; Ahmadzadehfar H; Fischer HP; Palmedo H; Bucerius J; Reinhardt MJ; Biersack HJ
J Nucl Med; 2006 Feb; 47(2):223-33. PubMed ID: 16455627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
